Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
In Thousands, except Share data
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2013 $ 6,512 $ 0 $ 6 $ 33,235 $ (1) $ (26,728)
Balance (in shares) at Dec. 31, 2013   0 5,834,083      
Issuance of common stock in exchange for exercise of warrants ($4.25 per share) 4,758 0 1 4,757 0 0
Issuance of common stock in exchange for exercise of warrants ($4.25 per share) (in shares)   0 1,119,746      
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 40,654 0 3 40,651 0 0
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 (in shares)   0 2,898,550      
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) 608 0 0 608   0
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) (in shares)   0 50,000      
Stock based compensation 553 0 0 553 0 0
Foreign currency translation adjustment 2 0 0 0 2 0
Net loss (5,164) 0 0 0 0 (5,164)
Balance at Mar. 31, 2014 $ 47,923 $ 0 $ 10 $ 79,804 $ 1 $ (31,892)
Balance (in shares) at Mar. 31, 2014   0 9,902,379